retatrutide approved in other countries ESC 2024: improves lipid and cardiovascular risk profile Phase II trial Retatrutide for the treatment of
Description
Remarkably, the DNA from all three mammalian species (rat, hamster, human) encoded the identical GLP-1 sequence, which differed from the fish DNA
The newest weight-loss drug, called retatrutide, could help people lose 30% of body weight, based on recent clinical trials
doi: 10.1016/S1542-3565(24)00910-8 FDA
While semaglutide GLP-1 is a valuable tool for weight management, its important to set realistic expectations
HDAC4: histone deacetylase 4
